Large‐scale production and purification of complexes between Clostridium botulinum neurotoxin and haemagglutinin have been achieved. Haemagglutinin‐free neurotoxic protein of the complexes was purified to high specific neurotoxicity by affinity chromatography. on p ‐aminophenyl β‐D‐thiogalactopyranoside coupled to Sepharose 4B, followed by chromatography on DEAE‐Sephacel. The resultant neurotoxin was homogeneous on isoelectric focussing (PI = 6.3) and on dodecylsulphate/polyacrylamide gel electrophoresis under non‐reducing conditions when its M r wits 1.4 × 10 5 ; after reduction two polypeptides (M r = 9.9 and 5.5 × 10 4 ) were present. On double‐ininiunodiffusion gels, using antiserum against neurotoxin‐haemagglutinin complex, the neurotoxin showed a single, sharp precipitin line that was immunologically distinct from a relatively non‐toxic protein (M r = 1.3 × 10 5 ). which co‐purifies with the neurotoxin but is removed by the ion‐exchange chromatography step. Application of the neurotoxin to animtils in vitro or in vivo produced near complete and irrevenible blockade of neurotransniission. Botulitiisation of rat leg muscles reduced spontaneous transmitter release; the amplitude of miniature end‐plate potentials was altered from the normal ‘bell‐shaped’ to II skewed distribution. In normal muscle, a large transient increase in frequency of the miniatures was produced by β‐bungaro‐toxin. In contrast. with botulinised muscle the latter induced a much smaller increase in the absolute frequency; in addition. the mean amplitude was increased somewhat but the distribution remained skewed. The results show botulinisation of. muscle modifies the action of β‐bungarotoxin.
No takes yet. Share an insight, caveat, or question.
Tse et al. (1982) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: